How Oral TKIs are Rewriting the Frontline and Pretreated Landscape in HER2-Mutant NSCLC
A new generation of oral HER2-targeted therapies is transforming advanced NSCLC care, delivering durable responses, brain metastasis control, and personalized treatment beyond traditional chemotherapy.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.